Scientific research is essential in promoting our understanding of rare diseases and for developing novel and life-changing therapies. Dr Sanja Brolih, from the University of Oxford, has been working on the rare inherited anaemia called Congenital Dyserythropoietic Anaemia Type 1 (CDA-1). Her work uses a variety of biochemical and biophysical techniques to characterise CDIN1, the disease protein of CDA-1.
With funding from CAN, Sanja has been able to share her research on CDA-1 across national, European and international stages. The funding has also allowed her to attend the British Haematology Conference in Glasgow, where her poster won first prize and earned her an invitation to present at the European Haematology Conference in Milan, Italy. There, her CDA-1 work received the EHA–JSH Travel Competition Award, enabling her to travel to Japan and showcase her research on a global platform.
Through these opportunities Sanja has been able to raise awareness of CDA-1 and CAN, while fostering new collaborations that drive forward vital research into new therapies for patients.
Sanja says: “None of these achievements would have been possible without CAN’s invaluable involvement. We extend our heartfelt thanks to everyone who made this journey possible. Together, we will continue to raise awareness of rare anaemias and promote translational research and global collaboration to improve patient outcomes.”